News Releases
Progressive Care Expands COVID-19 Testing Capabilities to Meet Increased Demand
MIAMI, FL – July 14, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that it has sold through over 90% of its COVID-19 Antibody testing kits. The Company has ordered additional kits and will be expanding testing to meet increasing needs.
July 13, 2020
Progressive Care Launches ClearMetrX Data Analytics Service
MIAMI, FL – June 30, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced the launch of ClearMetrX, the Company’s first wholly-owned data analytics company with services designed to support health care organizations across the country.
June 30, 2020
Progressive Care Announces May 2020 Performance Data: 62% Y/Y Sales Growth on Robust Execution and Expanding Market Share
MIAMI, FL – June 22, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for May 2020, including strong year-over-year growth in the face of continued intense downward pressure from tightening provider prescription demand, with strong execution, patient growth, and expanding Federally Qualified Health Centers (FQHCs) dispensing fees driving robust systemwide performance.
June 23, 2020
Progressive Care Changes Independent Public Accounting Firm to Daszkal Bolton LLP
MIAMI, FL – June 22, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, has engaged Daszkal Bolton LLP as its new independent public accounting firm as it undertakes efforts to transition to reporting under the Exchange Act Reporting requirements.
June 22, 2020
Progressive Care Issues 2020 Mid-Year Corporate Update
MIAMI, FL– June 12, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”),a personalized healthcare services and technology company, is pleased to issue the following progress update as the Company prepares for an exciting second half of 2020.
June 12, 2020
Progressive Care Begins Construction at 400 Ansin Building and Satisfies Seller’s Note
MIAMI, FL– June 1, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”),a personalized healthcare services and technology company, is pleased to announce that the Company has selected Atlas Construction and Management LLC (the “Contractor” or “Atlas”)for the construction project at 400 Ansin Blvd in Hallandale Beach, FL.
June 1, 2020
Progressive Care Announces April 2020 Performance: Continued Strong Growth Amid Challenging Context
MIAMI, FL – May 20, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for April 2020, which represented a very challenging context given clear COVID-19 factors, but also featured strong growth in net sales, prescriptions filled, 340B income, and total patients served, as well as the nationwide launch of our new e-commerce platform and antibody testing program.
May 20, 2020
Join our CEO, Shital Mars, as she answers the most relevant questions related to COVID-19 regarding reopening, testing, second wave, and more.
Join our CEO, Shital Mars, as she answers the most relevant questions related to COVID-19 regarding reopening, testing, second wave, and more.
May 19, 2020
Progressive Care Reports Q1 Performance, Net Sales Surpass $9 Million Amid COVID-19 Impact
MIAMI, FL – May 18, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to report financial results for the quarter ended March 31, 2020, which featured very strong revenue growth, especially considering the unique operating conditions during February and March due to the SARS-CoV-2 global pandemic health crisis. During the associated earnings call, management outlined specific competitive advantages and new initiatives positioning the Company for strong growth across all major metrics throughout 2020.
May 18, 2020
Progressive Care Launches COVID-19 IgG/IgM Rapid Result Antibody Testing Program 
MIAMI, FL – May 14, 2020 – Progressive CareInc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is very pleased to announce that the company has obtained the immediate capacity to market and distribute rapid-results antibody test kits (COVID-19 IgG/IgM) registered through the FDA under its emergency Use Authorization (“EUA”) guidelines for conducting SARS-CoV-2antibody presence and COVID-19 infection diagnosis testing.
May 14, 2020
Investors' Presentation